SCHEMBL11933620

SCHEMBL11933620

Cc1cc(C)c(-c2cc3ccccc3[n+](C)c2)c(C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 2/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2A6 P11509 1/20 0.40
▸ MAPT P10636 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ RAPGEF4 Q8WZA2 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ ATM Q13315 2/20 0.34
▸ FFAR4 Q5NUL3 1/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ JAK2 O60674 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ RAD52 P43351 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ ACHE P22303 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11933622 0.81 CYP1A2 (0.41) TERTCYP1A2CYP2A6MAPTNPSR1
SCHEMBL17193116 0.77 TERT (0.44) TERTCYP1A2CYP2A6MAPTNPSR1
SCHEMBL12075034 0.75 TERT (0.43) TERTHTTATMMEN1RAB9A
SCHEMBL11075087 0.72 RAPGEF4 (0.37) TERTCYP1A2CYP2A6MAPTNPSR1
SCHEMBL11933621 0.71 CA12 (0.44) TERTRAB9AGAA
SCHEMBL1133224 0.70 CYP2A6 (0.54) CYP1A2CYP2A6TDP1ALDH1A1
SCHEMBL15625680 0.69 RAB9A (0.47) TERTCYP1A2MAPTMEN1RAB9A
SCHEMBL9750621 0.68 TERT (0.43) TERTMAPTHTTTDP1ATM
SCHEMBL1133458 0.68 PSMB5 (0.46) CYP1A2CYP2A6MAPTHTTFFAR4
SCHEMBL28273210 0.68 CYP1A2 (0.40) TERTCYP1A2CYP2A6MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4249494-A2 USE OF A RADICAL GENERATING CATALYST AND METHOD FOR PRODUCING OXIDATION REACTION PRODUCT Acenet Inc. (JP) 2023-09-27 — — EP disclosed
US-20230264181-A1 RADICAL GENERATING CATALYST, METHOD FOR PRODUCING RADICAL, METHOD FOR PRODUCING OXIDATION REACTION PRODUCT, DRUG, AND DRUG FOR AGRICULTURE AND LIVESTOCK ACENET INC (JP) 2023-08-24 — — US disclosed
US-11673129-B2 Radical generating catalyst, method for producing radical, method for producing oxidation reaction product, drug, and drug for agriculture and livestock ACENET INC. (JP) 2023-06-13 — — US disclosed
EP-3626339-A1 RADICAL-GENERATING CATALYST, RADICAL PRODUCTION METHOD, OXIDATION REACTION PRODUCT PRODUCTION METHOD, CHEMICAL AGENT, AND CHEMICAL AGENT FOR AGRICULTURE AND LIVESTOCK Acenet Inc. (JP) 2020-03-25 — — EP disclosed
EP-2479160-B1 PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND UNIV OSAKA (JP) 2015-09-09 — — EP disclosed
EP-2479160-A1 PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND Osaka University (JP) 2012-07-25 — — EP disclosed
US-20120171111-A1 PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND OSAKA UNIVERSITY (JP) 2012-07-05 — — US disclosed
US-20120171111-A1 PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND OSAKA UNIVERSITY (JP) 2012-07-05 — — US disclosed
US-7977486-B2 Quinolinium ion derivatives, process for the production of the derivatives, products made by using the same, and reduction and oxidation methods with the derivatives OSAKA UNIVERSITY (JP) 2011-07-12 — — US disclosed
WO-2011034071-A1 PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND 国立大学法人大阪大学 (JP) 2011-03-24 — — WO disclosed
US-20100004454-A1 QUINOLINIUM ION DERIVATIVES, PROCESS FOR THE PRODUCTION OF THE DERIVATIVES, PRODUCTS MADE BY USING THE SAME, AND REDUCTION AND OXIDATION METHODS WITH THE DERIVATIVES OSAKA UNIVERSITY (JP) 2010-01-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230264181-A1 RADICAL GENERATING CATALYST, METHOD FOR PRODUCING RADICAL, METHOD FOR PRODUCING OXIDATION REACTION PRODUCT, DRUG, AND DRUG FOR AGRICULTURE AND LIVESTOCK LPO, CAT, NOX4 TERT 975/4885CYP1A2 70/4885CYP2A6 92/4885
US-20120171111-A1 PROCESS FOR PRODUCTION OF OXIDATION REACTION PRODUCT OF AROMATIC COMPOUND TYR, AOX1, POR TERT 786/4885CYP1A2 90/4885CYP2A6 427/4885
US-20100004454-A1 QUINOLINIUM ION DERIVATIVES, PROCESS FOR THE PRODUCTION OF THE DERIVATIVES, PRODUCTS MADE BY USING THE SAME, AND REDUCTION AND OXIDATION METHODS WITH THE DERIVATIVES APEX1, NQO1, POT1 TERT 75/4885CYP1A2 2589/4885CYP2A6 4231/4885
US-11673129-B2 Radical generating catalyst, method for producing radical, method for producing oxidation reaction product, drug, and drug for agriculture and livestock LPO, CAT, NOX4 TERT 975/4885CYP1A2 70/4885CYP2A6 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback